Evidence map›Paper›PMID 23589617›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Role of nucleic acid-sensing TLRs in diverse autoantibody specificities and anti-nuclear antibody-producing B cells.

Yi Ting Koh, John C Scatizzi, Jennifer D Gahan, Brian R Lawson, Roberto Baccala, K Michael Pollard, Bruce A Beutler, Argyrios N Theofilopoulos, Dwight H Kono

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. B Cell Aberrance in Lupus: the Ringleader and the Solution.Clinical reviews in allergy & immunology · 2022
    Review
  6. Article
  7. The Role of Exposomes in the Pathophysiology of Autoimmune Diseases I: Toxic Chemicals and Food.Pathophysiology : the official journal of the International Society for Pathophysiology · 2021
    Review
  8. B Cell αv Integrins Regulate TLR-Driven Autoimmunity.Journal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  9. Article
  10. Functional Characterization of CD11cJournal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  11. Generation of functional murine CD11cEuropean journal of immunology · 2019
    Article
  12. Environmental Xenobiotic Exposure and Autoimmunity.Current opinion in toxicology · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. TLR10 Is a B Cell Intrinsic Suppressor of Adaptive Immune Responses.Journal of immunology (Baltimore, Md. : 1950) · 2017
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yi Ting KohDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.
John C Scatizzi
Jennifer D Gahan
Brian R Lawson
Roberto Baccala
K Michael Pollard
Bruce A Beutler
Argyrios N Theofilopoulos
Dwight H Kono
Scripps Research Institute · USSouthwestern Medical Center · US

Funding

Genetic Basis of Systemic AutoimmunityR37AR039555 · NIAMS · SCRIPPS RESEARCH INSTITUTE, THE · PI THEOFILOPOULOS, ARGYRIOS N · 2003 to 2012
$4.2M
Defining the effector gene repertoire in systemic autoimmunity by ENU mutagenesisR01AR053731 · NIAMS · SCRIPPS RESEARCH INSTITUTE, THE · PI KONO, DWIGHT H · 2007 to 2011
$2.5M
Role of Daf in Systemic AutoimmunityR01ES014847 · NIEHS · SCRIPPS RESEARCH INSTITUTE, THE · PI POLLARD, KENNETH MICHAEL · 2008 to 2012
$1.9M
T CELL ANTIGEN RECEPTOR GENES IN AUTOIMMUNITYR01AR039555 · NIAMS · SCRIPPS RESEARCH INSTITUTE · PI THEOFILOPOULOS, ARGYRIOS N · 1988 to 2002
$1.4M
NIAMS NIH HHS AR39555NIAMS NIH HHS AR53731NIAMS NIH HHS R01 AR039555NIAMS NIH HHS R01 AR053731NIAMS NIH HHS R37 AR039555NIEHS NIH HHS ES14847NIEHS NIH HHS R01 ES014847PHS HHS T32 A1007244-26
6 · The paper itself

Abstract

Nucleic acid (NA)-sensing TLRs (NA-TLRs) promote the induction of anti-nuclear Abs in systemic lupus erythematosus. However, the extent to which other nonnuclear pathogenic autoantibody specificities that occur in lupus and independently in other autoimmune diseases depend on NA-TLRs, and which immune cells require NA-TLRs in systemic autoimmunity, remains to be determined. Using Unc93b1(3d) lupus-prone mice that lack NA-TLR signaling, we found that all pathogenic nonnuclear autoantibody specificities examined, even anti-RBC, required NA-TLRs. Furthermore, we document that NA-TLRs in B cells were required for the development of antichromatin and rheumatoid factor. These findings support a unifying NA-TLR-mediated mechanism of autoantibody production that has both pathophysiological and therapeutic implications for systemic lupus erythematosus and several other humoral-mediated autoimmune diseases. In particular, our findings suggest that targeting of NA-TLR signaling in B cells alone would be sufficient to specifically block production of a broad diversity of autoantibodies.

Indexed as

AnimalsAntibodies, AntinuclearAntibody-Producing CellsAutoantibodiesB-LymphocytesBone Marrow CellsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesChromatinDendritic CellsFemaleImmunologic Deficiency SyndromesLupus Erythematosus, SystemicLymphocyte ActivationMacrophagesMembrane GlycoproteinsAntibodies, AntinuclearAutoantibodiesChromatinMembrane GlycoproteinsMembrane Transport ProteinsMyd88 protein, mouseMyeloid Differentiation Factor 88Nucleic AcidsRheumatoid FactorRibonucleoproteinsTlr7 protein, mouseTlr9 protein, mouseToll-Like Receptor 7Toll-Like Receptor 9UNC93B1 protein, mouse

Identifiers

PMID23589617
PMCPMC3729324
OpenAlexW2109508249

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.